1
Clinical Trials associated with SAR-438544A Randomized, Double-blind, Glucagon and Placebo-controlled Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Single Escalating Doses of SAR438544 Administered by Subcutaneous Route in Healthy Subjects and Patients With Type 1diabetes Mellitus
Primary Objective:
To assess the tolerability and safety of SAR438544 after single ascending subcutaneous (SC) doses in healthy subjects and in type 1 diabetes mellitus (T1DM) patients.
Secondary Objective:
To assess the preliminary pharmacodynamics (PD) and pharmacokinetic (PK) parameters of SAR438544 after single ascending SC doses in healthy subjects and in T1DM patients.
100 Clinical Results associated with SAR-438544
100 Translational Medicine associated with SAR-438544
100 Patents (Medical) associated with SAR-438544
100 Deals associated with SAR-438544